Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1165 results for "ranbaxy"

Sun-Ranbaxy deal under CCI scanner
Times of India

CCI worried about molecular effect of Sun-Ranbaxy merger

The Competition Commission of India, which has put the $4-billion Sun-Ranbaxy merger deal under public scrutiny, said on Friday the major issue is whether the combination would result in high market concentration of certain molecules. This is the ... Domain-B, 10 hours ago
Sun-Ranbaxy deal under CCI scanner Times of India, 1 day ago
Concern over drug deal The Telegraph, 1 day ago
[x]  

84 images for ranbaxy

Deccan Chronicle, 1 day ago
Business Today India, 1 day ago
Times of India, 1 day ago
NDTV, 1 day ago
India TV, 2 days ago
Deccan Chronicle, 2 days ago
Financial Express, 2 days ago
4 Traders, 2 days ago
Business Today India, 2 days ago
NDTV, 2 days ago

Competition Commission of India concerned on Sun-Ranbaxy deal

Ashok Chawla New Delhi: Competition Commission of India (CCI) is scrutinising whether the $4 billion Sun-Ranbaxy deal would result in high market concentration of certain molecules. The major issues obviously are that in many of the molecules, ...
 Deccan Chronicle1 day ago CCI concerned on Sun-Ranbaxy deal  Asian Age1 day ago

High-market concentration in some molecules is major issue in Sun Pharma-Ranbaxy deal: CCI Chairman

The major issue being probed in the multi-billion dollar Sun Pharma-Ranbaxy deal is to see if there is a high-market concentration in some molecules which will emerge as result of the proposed merger and acquisition (M&A) deal, chairman of the ...
 Meri News1 day ago High-market concentration major issue in Sun Pharma-Ranbaxy deal: CCI chairman  Myiris1 day ago

Competition Commission of India puts Sun-Ranbaxy deal under public scrutiny

Comment · print · T T T+· T- TOPICS The deal was approved last month by leading stock exchanges BSE and NSE. The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, on Friday, said the ...
 The Hindu1 day ago
Rediff.com

RANBAXY LABORATORIES : may face another hefty fine in the US of Rs 240 crore

NEW DELHI : Ranbaxy Laboratories may have to pay another hefty fine in the United States of close to Rs 240 crore , this time imposed by the State of Texas , people familiar with the matter told ET. The company has been in negotiation with the US ...
 4 Traders2 days ago Ranbaxy Laboratories clarifies on news report  MyIris5 days ago Ranbaxy Laboratories Ltd clarifies on Rs. 242 crores fine  Equity Bulls4 days ago RANBAXY LABORATORIES : FACING Rs240 CRORE FINE IN TEXAS  4 Traders5 days ago
[x]  

Sun Pharma, Ranbaxy slip; CCI asks more details of merger

Sun Pharma and Ranbaxy, which had announced a USD 4-billion deal in April this year, were asked by CCI on Wednesday to make public details of their proposed transaction in a "prescribed format" within 10 working days.
 Money Control2 days ago Ranbaxy, Sun Pharma receives communication from CCI for their merger  MyIris2 days ago CCI asks Ranbaxy and Sun Pharma for details on proposed merger  Myiris2 days ago Ranbaxy Labs. - Communication received from the Competition...  SBICAP Securities3 days ago
Livemint.com

Competition Commission extends Sun Pharma-Ranbaxy probe to new stage

Sun Pharma agreed to buy Ranbaxy for $3.2 billion in stock from its Japanese parent Daiichi Sankyo in a deal that would create the world's fifth largest generic drugmaker. Photo: Bloomberg New Delhi: India's antitrust regulator has ordered a ...
 Livemint.com2 days ago Ranbaxy-Sun Pharma merger awaits Competition Commission nod  Money Control1 week ago TALKS ON TO GET COMPETITION PANEL NOD FOR RANBAXY DEAL: SUN PHARMA CHIEF  TMC Net1 week ago RANBAXY LABORATORIES : Talks on to get competition panel nod for ranbaxy deal: sun pharma chief  4 Traders1 week ago
[x]  
Money Control

Here are top 10 stocks to keep an eye on August 25

Here are top 10 stocks to keep an eye on August 25 - Reliance Industries, Yes Bank, Maruti, Ranbaxy, Glenmark Pharma, United Brewries, United Spirits, Hindalco, JSPL and Kolte Patil.
 Money Control6 days ago Here are top 10 stocks to focus on August 22  Money Control1 week ago Stocks in news: Tilaknagar, United Spirits, Ranbaxy, MCF  Money Control1 week ago Top10 stocks to watch on July 14  Money Control1 month ago

Ranbaxy Laboratories to hold EGM

This page uses frames, but your browser doesn't
 Capital Market1 week ago Stay with Ranbaxy Laboratories: Hemen Kapadia  Money Control1 week ago Hold Ranbaxy Laboratories, says Ashu Madan  Money Control1 week ago Ranbaxy Laboratories' AGM on July 28, 2014  Money Control1 month ago
Business Standard

Ranbaxy hits 52-week high on UBS upgrade

MUMBAI: Shares of Ranbaxy Laboratories gained momentum for fourth consecutive session to hit 52-week high after UBS raised its target price. According to the brokerage, the stock is a cheaper way to buy Sun Pharmaceuticals. It will benefit from ...
 Economic Times5 days ago Ranbaxy hits record high, UBS raises target to Rs 784  Smart Investor6 days ago Ranbaxy hits 52-week high in volatile trade  Capital Market1 month ago Pharma shares in demand; Healthcare index hits new high  Business Standard1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less